LeonaBio, Inc. (LONA)
6.34
-0.45
(-6.63%)
USD |
NASDAQ |
Sep 21, 16:00
6.34
0.00 (0.00%)
After-Hours: 20:00
LeonaBio Total Liabilities (Quarterly) : 23.30M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.30M |
| March 31, 2026 | 22.29M |
| December 31, 2025 | 177.22M |
| September 30, 2025 | 3.247M |
| June 30, 2025 | 3.559M |
| March 31, 2025 | 6.183M |
| December 31, 2024 | 13.94M |
| September 30, 2024 | 28.66M |
| June 30, 2024 | 27.92M |
| March 31, 2024 | 26.72M |
| December 31, 2023 | 30.06M |
| September 30, 2023 | 29.94M |
| June 30, 2023 | 23.07M |
| March 31, 2023 | 21.65M |
| Date | Value |
|---|---|
| December 31, 2022 | 23.02M |
| September 30, 2022 | 11.94M |
| June 30, 2022 | 11.45M |
| March 31, 2022 | 11.02M |
| December 31, 2021 | 10.92M |
| September 30, 2021 | 11.09M |
| June 30, 2021 | 9.415M |
| March 31, 2021 | 6.197M |
| December 31, 2020 | 5.281M |
| September 30, 2020 | 8.469M |
| June 30, 2020 | 6.923M |
| March 31, 2020 | |
| December 31, 2019 | 4.861M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.605M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 112.90M |
| Fulcrum Therapeutics, Inc. | 13.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.89M |
| Shareholders Equity (Quarterly) | 33.60M |
| Debt to Equity Ratio | 0.0172 |
| Current Ratio | 7.011 |
| Net Debt Paydown Yield | 0.12% |